| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10486417 | Value in Health | 2011 | 5 Pages |
Abstract
From the perspectives of the BNHI and society in Taiwan, capecitabine not only saves costs but also improves health outcomes compared with 5-FU/LV in the adjuvant treatment of stage III colon cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Tzu-Chi MD, Hong-Hwa MD, Ming-Chin PhD, Hwei-Ming MD, Jye-Hann MD, Shu-Wen MD, Hsin-Chieh PhD, Chung-Yu MHA, Jen-Hao MBA, Li-Tzong MD, PhD,